Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
Annals of Surgical Oncology
|
April 21, 2001
Blue dye for sentinel lymph node mapping: not too sensitive, but too hypersensitive?
R S Krouse, R E Schwarz
The American Surgeon
|
August 31, 2000
Postoperative suppressive therapy for thyroid adenomas
R S Krouse, T McCarty, L M Weiss, et al.
The British Journal of Surgery
|
August 11, 2016
Prognostic significance of lymph node yield in ypN0 rectal cancer
M Raoof, R A Nelson, V N Nfonsam, et al.
Archives of Surgery (Chicago, Ill. : 1960)
|
August 4, 2001
Surgical palliation at a cancer center: incidence and outcomes
R S Krouse, R A Nelson, B R Farrell, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy
|
November 1, 1995
Thyroid dysfunction in 281 patients with metastatic melanoma or renal carcinoma treated with interleukin-2 alone
R S Krouse, R E Royal, G Heywood, et al.
The Cancer Journal From Scientific American
|
March 1, 1996
Correlates of response to IL-2 therapy in patients treated for metastatic renal cancer and melanoma
R E Royal, S M Steinberg, R S Krouse, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
Annals of Surgical Oncology
|
April 21, 2001
Blue dye for sentinel lymph node mapping: not too sensitive, but too hypersensitive?
R S Krouse, R E Schwarz
The American Surgeon
|
August 31, 2000
Postoperative suppressive therapy for thyroid adenomas
R S Krouse, T McCarty, L M Weiss, et al.
The British Journal of Surgery
|
August 11, 2016
Prognostic significance of lymph node yield in ypN0 rectal cancer
M Raoof, R A Nelson, V N Nfonsam, et al.
Archives of Surgery (Chicago, Ill. : 1960)
|
August 4, 2001
Surgical palliation at a cancer center: incidence and outcomes
R S Krouse, R A Nelson, B R Farrell, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy
|
November 1, 1995
Thyroid dysfunction in 281 patients with metastatic melanoma or renal carcinoma treated with interleukin-2 alone
R S Krouse, R E Royal, G Heywood, et al.
The Cancer Journal From Scientific American
|
March 1, 1996
Correlates of response to IL-2 therapy in patients treated for metastatic renal cancer and melanoma
R E Royal, S M Steinberg, R S Krouse, et al.
Page
of 1